Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<02315.HK> - BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.

 
 Stock Screener：Medicine, Pharmaceuticals, Biotechnology
HUTCHMED C.P. POKPHAND PAK FAH YEOW ALI HEALTH SIPAI HEALTH OCI INTL INNOVATIVE PHAR WANJIA GROUP TIANDA PHARMA SIHUAN PHARM LANSEN PHARMA GRAND PHARMA TRAD CHI MED PASHUN INT'L REGENT PACIFIC CONCH ENVIRO UNI-BIO GROUP SHANDONG XINHUA CKLIFE SCIENCES EXTRAWELL PHAR CMS BAIYUNSHAN PH WAI YUEN TONG ZHONG JIA GX QIANHAI HEALTH KING INTL INV SHUNTEN INTL C ANIMAL HEALTH LEE'S PHARM NT PHARMA ESSEX BIO-TECH CSPC PHARMA SINOPHARM KINGWORLD CMBC CAPITAL CGN MINING JACOBIO-B SINO BIOPHARM CANBRIDGE-B 3D MEDICINES KONTA CHINA SH PIONEER HLDG FUDANZHANGJIANG OCUMENSION-B PURAPHARM LIVZON PHARMA FRONTAGE 3SBIO IMMUNEONCO-B GENSCRIPT BIO HEC CJ PHARM MODERN CHI MED FUSEN PHARM TONG REN TANG ASCLETIS-B CONSUN PHARMA CIRC INNOVENT BIO VIVA BIOTECH TOT BIOPHARM-B JUNSHI BIO SANAI HEALTH GP EVEREST MED-B SSY GROUP SIMCERE PHARMA LAEKNA-B JW THERAP-B BRII-B HBM HOLDINGS-B LEPU BIO-B JBM HEALTHCARE KEYMED BIO-B BASECARE-B CARSGEN-B RECBIO-B MABPHARM-B LUYE PHARMA FOSUN PHARMA CLOVER BIO-B UNI HEALTH ABBISKO-B SIRNAOMICS-B WUXI XDC WUXI BIO CHARMACY PHAR DAWNRAYS PHARMA WUXI APPTEC GIANT BIOGENE LUZHU BIOTECH-B CUTIA-B YZYBIO-B QYUNS-B HIGHTIDE-B HUA MEDICINE-B SH PHARMA CSTONE PHARMA-B JACOBSON PHARMA HENLIUS SHINEWAY PHARM LONGRUN TEA CHINARES PHARMA SINOLIFE UTD TIGERMED TYCOON GROUP TONGRENTANGCM SINOMAB BIO-B HANSOH PHARMA ZHONGZHIPHARM PHARMARON CT ENTERPRISE UNITED LAB NEW RAY MEDIC AUSTAR JOINN BEIGENE CANSINOBIO SCICLONE PHARMA JD HEALTH ZHAOKE OPHTH-B TRANSCENTA-B AIM VACCINE MEGA GENOMICS ASYMCHEM HAOHAI BIOTEC SINCO PHARMA ASCENTAGE-B HINSANG GROUP GOLDEN THROAT BOAN BIOTECH IMMUNOTECH-B SKB BIO-B ANTENGENE-B GENOR-B HAO WEN HLDGS CB GLOBAL CH BIOTECH SER JILIN CHANGLONG CH DEMETER FIN GF HEALTHCARE CRMI BAYTACARE PHARM C HEALTH GP BIOSINO BIO-TEC SILK RD ENERGY NEP INTERLONG LARRY JEWELRY HUAKANG BIOMED
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
BIOCYTOGEN-B 500 -11.38 3.5837 -1.0524 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-08-22　生物製藥及臨床前研發服務公司百奧賽圖（2315）上周五開始招股，集資約5.49億元。集團利用獨有專利技術，提供生物醫藥研發及臨床試驗外包（CRO）雙線服務，業務較為獨特。
 
2022-08-22　百奧賽圖（2315）業務可分為藥物開發及臨床前研究服務兩大範疇。在藥品開發業務方面，又可分為腫瘤學和自身免疫性疾病治療研發，及抗體開發業務。集團兩個核心產品：YH003主要針對胰腺導管腺癌、黑色素瘤及其他實體瘤的治療；YH001則主要針對非小細胞肺癌、肝細胞癌及其他實體瘤的治療。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 04-24 09:30 16944.3 ▲ 115.42 ▲ 0.69%
BIOCYTOGEN-B 04-26 15:59 8.3 ▲ 8.3 ▲ ∞%
≫More
 
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.